Dihydrodipicolinate synthase (DHDPS) catalyses the first committed step in the lysine-biosynthesis pathway in bacteria, plants and some fungi. In this study, the expression of DHDPS from Bacillus anthracis (Ba-DHDPS) and the purification of the recombinant enzyme in the absence and presence of the substrate pyruvate are described. It is shown that DHDPS from B. anthracis purified in the presence of pyruvate yields greater amounts of recombinant enzyme with more than 20-fold greater specific activity compared with the enzyme purified in the absence of substrate. It was therefore sought to crystallize Ba-DHDPS in the presence of the substrate. Pyruvate was soaked into crystals of Ba-DHDPS prepared in 0.2 M sodium fluoride, 20%(w/v) PEG 3350 and 0.1 M bis-tris propane pH 8.0. Preliminary X-ray diffraction data of the recombinant enzyme soaked with pyruvate at a resolution of 2.15 Å are presented. The pending crystal structure of the pyruvate-bound form of Ba-DHDPS will provide insight into the function and stability of this essential bacterial enzyme.
Introduction
The lysine-biosynthetic pathway in bacteria, also known as the diaminopimelate (DAP) pathway, leads to the de novo synthesis of lysine, which is essential for protein synthesis. Equally important is the immediate precursor to lysine, meso-DAP, which is a vital constituent of the bacterial cell wall, where it is incorporated into the peptidoglycan layer (Hutton et al., 2007) . The reaction catalyzed by DHDPS is the first committed step in this pathway and involves the condensation of pyruvate and (S)-aspartate semialdehyde [(S)-ASA] to form (4S)-4-hydroxy-2,3,4,5-tetrahydro-(2S)-dipicolinic acid (HTPA; Blickling et al., 1997) . The reaction proceeds via a ping-pong kinetic mechanism in which pyruvate binds as a Schiff base to an active-site lysine residue (Lys163 for Bacillus anthracis DHDPS), resulting in the formation of an imine. Tautomerization of the Schiff base to an enamine then occurs, although the exact mechanism of this step is unknown. (S)-ASA then reacts with this enamine and following cyclization forms the product HTPA (Blickling et al., 1997) .
The structure of ligand-free DHDPS has been determined for a number of species of bacteria, including B. anthracis (Blagova et al., 2006) , Escherichia coli (Dobson et al., 2005) , Mycobacterium tuberculosis (Kefala et al., 2008) , Thermoanaerobacter tengcongensis (Wolterink-van Loo et al., 2008) , Thermotoga maritima (Pearce et al., 2006) and methicillin-resistant Staphylococcus aureus (MRSA; Burgess et al., 2008) . The structure of the enzyme bound to pyruvate has also recently been solved for DHDPS from E. coli (PDB code 3du0; Devenish et al., 2008) and S. aureus (PDB code 3di1; Girish et al., 2008) . The enzyme usually assembles as a tetrameric protein, best described as a dimer of tight dimers, although an active dimeric form has recently been reported for DHDPS from MRSA (Burgess et al., 2008) . Each monomer is an (/) 8 -barrel, with the active site situated near the central cavity of the barrel. For those enzymes inhibited by lysine, two allosteric binding sites are located at the tight dimer interface, displaced from the active site (Dobson et al., 2004) .
DHDPS enzymes from plants (Frisch et al., 1991; Dereppe et al., 1992) and some Gram-negative bacteria (Laber et al., 1992) are feedback-regulated by lysine acting as an allosteric modulator through partial inhibition of catalytic activity. However, allosteric regulation by lysine at biologically relevant concentrations has not been found in DHDPS enzymes from Gram-positive species (Cremer et al., 1988; Burgess et al., 2008) and thus the regulatory mechanism of these enzymes is not yet understood. Interestingly, recent studies show that pyruvate, the first substrate to bind to the DHDPS enzyme (Dobson et al., 2004) , stabilizes the oligomeric structure of DHDPS from MRSA (Burgess et al., 2008) . In this study, we therefore aimed to express, purify and soak crystals of recombinant B. anthracis DHDPS (Ba-DHDPS) with the substrate pyruvate. We show that when purified in buffers containing pyruvate the recombinant Ba-DHDPS enzyme has a significantly higher specific activity than Ba-DHDPS purified in the absence of pyruvate. Therefore, it is of interest to examine the crystal structure of the enzyme soaked with this substrate.
Methods and materials 2.1. Cloning and expression of Ba-DHDPS
The dapA gene encoding Ba-DHDPS was amplified from genomic DNA extracted from the B. anthracis Sterne strain using the primers 5 0 -TCAGCAGATAGTCATACGAC-3 0 and 5 0 -TGAAGAACTGGT-TAATGATC-3 0 . The PCR product was then ligated into pCR-BluntII-TOPO and transformed into E. coli One Shot TOP10. The dapA insert was then amplified from pCR-BluntII-TOPO/dapA using the primers 5 0 -CATATGATAGATTTTGGGACAAT-3 0 and 5 0 -GA-TCCTTAACGAGGGATAGATTGCA-3 0 , which contain NdeI and BamHI restriction-endonuclease sites, respectively. The product, which now contains NdeI and BamHI restriction-endonuclease sites, was ligated into pCR-BluntII-TOPO and transformed into E. coli One Shot TOP10, which enables efficient ligation into an expression vector. The resulting plasmid and pET-11a were digested using the restriction enzymes NdeI and BamHI and subsequently electrophoresed on a 1%(w/v) agarose gel. DapA and linearized pET-11a were excised from the gel and purified before being ligated with T4 DNA ligase and transformed into E. coli BL21(DE3).
A 4 l expression of E. coli BL21-DE3(pET-11a/dapA) took place in Luria Broth containing 100 mg ml À1 ampicillin at 310 K with shaking until an OD 600 of 0.6 was achieved. Expression of recombinant Ba-DHDPS was attained following the addition of IPTG to a final concentration of 1.0 mM and subsequent incubation at 310 K for a further 3 h. Cells were then pelleted at 10 000g for 15 min at 277 K, resuspended in 20 mM Tris-HCl pH 8.0 and frozen at 253 K until needed.
Purification of Ba-DHDPS
Ba-DHDPS was purified using two approaches: in the absence of pyruvate (preparation 1) and in the presence of pyruvate (preparation 2). Cells were thawed on ice for 2 h and lysed by sonication with an MSE Soniprep 150 sonicator at 14 mm amplitude. A cycle involving 8 min of 3 s bursts followed by 10 s rests was employed. The preparation was then centrifuged at 10 000g for 17 min at 277 K and the supernatant was subsequently collected and filtered through a 0.45 mm membrane. The crude extract was then injected onto a Q Sepharose column pre-equilibrated in buffer A (20 mM Tris-HCl pH 8.0 for preparation 1 and 20 mM Tris-HCl, 5 mM pyruvate pH 8.0 for preparation 2) at 277 K. The column was then washed with buffer A until a stable baseline was reached. Elution of bound protein was performed over five column volumes using a 0-1.0 M NaCl gradient in buffer A and 10 ml fractions were collected. DHDPS-containing fractions were pooled and ammonium sulfate was added to a final concentration of 500 mM. Pooled fractions were injected onto a Phenyl Sepharose column pre-equilibrated in buffer B (20 mM Tris-HCl, 500 mM ammonium sulfate pH 8.0 for preparation 1 and 20 mM Tris-HCl, 500 mM ammonium sulfate, 5 mM pyruvate for preparation 2) at 277 K. The protein was eluted using a five-column-volume gradient of 500-0 mM ammonium sulfate with 10 ml fractions collected at 277 K. Peak fractions were pooled, separated into 1 ml aliquots, flash-frozen in liquid nitrogen and stored at 193 K. Prior to use, protein samples were thawed and loaded onto a 5 ml HiTrap Desalting column for buffer exchange into the desired buffer.
Coupled kinetics assay
Kinetic analysis of Ba-DHDPS was performed using a coupled assay employing Ba-DHDPS and E. coli dihydrodipicolinate reductase (DHDPR; Coulter et al., 1999) . DHDPR was considered to be in excess when a twofold concentration increase did not affect the initial rate. Assays were performed in triplicate in 1.5 ml reduced-volume 10 mm path-length acrylic cuvettes in 200 mM bis-tris propane, 150 mM NaCl pH 8.0 at 303 K.
Crystallization of Ba-DHDPS
For crystallization trials, a solution of 14 mg ml À1 Ba-DHDPS in 20 mM Tris-HCl pH 8.0 was prepared. Initial protein-crystallization experiments were performed at the CSIRO node of the Bio21 Collaborative Crystallization Centre (C3; http://www.csiro.au/c3/) using the PACT Suite and the JCSG+ Suite crystal screens (Qiagen) at 281 and 293 K. These initial screens were set up using the sittingdrop vapour-diffusion method with droplets consisting of 100 nl protein solution and 100 nl reservoir solution. Reagents containing a variety of polyethylene glycols as precipitants gave a number of crystal forms at 281 and 293 K. These conditions were scaled up using the hanging-drop vapour-diffusion method with drops consisting of 2 ml protein solution and 2 ml precipitant solution at 277 K. Again, a variety of crystal forms were observed from a number of different conditions. The crystals with the best morphology were soaked with 4 ml 20 mM pyruvate in 50% reservoir solution. The best diffracting crystal (Fig. 1) 
Data collection and processing
For X-ray data collection, the crystal was transferred to reservoir solution containing 20%(v/v) glycerol with 20 mM pyruvate and directly flash-frozen in liquid nitrogen. Intensity data were collected at 110 K at the Australian Synchrotron on the 3-BM1 beamline (McPhillips et al., 2002; Evans & Pettifer, 2001 ) using X-rays with a wavelength of 0.9536 Å . Data were collected in 0.5 steps for one 360 pass with an ADSC Q210r image-plate detector positioned 200 mm from the crystal with an exposure time of 5 s. Diffraction data sets were processed and scaled using MOSFLM (Leslie, 1991) and SCALA (Collaborative Computational Project, Number 4, 1994) .
Results and discussion
When Ba-DHDPS was purified in the presence of pyruvate (preparation 2), we observed a 22-fold increase in specific activity relative to using the same approach without pyruvate in the buffers used during purification (preparation 1) (Table 1) . Similarly, the yield increased from 36.3% for preparation 1 to 98.0% for preparation 2 (Table 1 ). This phenomenon is reproducibly observed and thus cannot be attributed to batch variation. Interestingly, primary kinetic data obtained using the coupled assay (Coulter et al., 1999) revealed a nonlinear reaction profile that activated as a function of time when the recombinant enzyme was purified in the absence of pyruvate (Fig. 2) . This is often attributed to a lack of coupling enzyme (DHDPR); however, in this case increasing the coupling enzyme did not change the profile. In contrast, recombinant Ba-DHDPS from preparation 2 purified in the presence of pyruvate displayed linear and ideal kinetic behaviour (Fig. 2) . This is interesting considering that a recent study showed that pyruvate stabilizes the most active oligomeric form of DHDPS from methicillin-resistant S. aureus (Burgess et al., 2008) . Given this recent study and our results as summarized in Table 1 and Fig. 2 , we therefore sought to crystallize Ba-DHDPS bound to the substrate pyruvate.
Ba-DHDPS in the presence of pyruvate crystallized under identical conditions to the pyruvate-unbound form of the enzyme (Blagova et al., 2006) . The crystal shown in Fig. 1 appeared after 3 
Figure 2
Primary kinetic data comparing Ba-DHDPS purified in the absence (preparation 1) and presence (preparation 2) of pyruvate. The reaction was initiated at 0.4 min.
Figure 3
X-ray diffraction pattern from the Ba-DHDPS crystal soaked with pyruvate. 2.15 Å refers to the highest resolution spots observed in the outer circle. and continued to grow to 50 mm in the longest dimension over a further 10 d. Diffraction data were collected from several crystals after soaking with pyruvate, which produced data with a resolution ranging between 2.15 and 2.60 Å . The highest resolution (2.15 Å ) data are shown in Fig. 3 and were scaled and merged for analysis. Similar to the previously reported ligand-free Ba-DHDPS structure (Blagova et al., 2006) , the space group was determined to be P2 1 2 1 2 1 , with almost identical unit-cell parameters a = 84.5, b = 124.6, c = 131.0 Å . The Matthews coefficient (V M ) was calculated to be 2.8 Å 3 Da À1 , with an estimated solvent content of 54%. Scaling and merging of the crystallographic data resulted in an overall R merge of 0.086, with an R merge in the highest resolution shell of 0.27. Complete data-collection statistics are given in Table 2 .
Molecular replacement using the program Phaser (McCoy, 2007) with the pyruvate-unbound DHDPS from B. anthracis as a search model (PDB code 1xky) showed the presence of four monomers in the asymmetric unit. The first round of refinement gave an R free of 23.2% and an R factor of 25.5% and close inspection of the active site showed the presence of electron density consistent with pyruvate bound to Lys163. Further model building and refinement is currently under way. We anticipate that this structure will provide insight into the improved yield and specific activity of the enzyme following purification of Ba-DHDPS in the presence of the substrate (Table 1) and the enhanced enzyme-kinetic activity reported in Fig. 2. 
